Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

Recruiting now · Phase 1/Phase 2

Conditions studied: Keloid

In brief

Keloids are often described as benign dermal fibroproliferative lesions characterized by increased growth beyond the boundaries of the original wound margin.Fibroblasts are considered to be the key cellular mediators of fibrogenesis in keloid scars. Thus this prospective study is going to investigate whether 68Ga-RGD PET/CT may provide evidence for diagnosis and evaluate the effectiveness of treatment.

Key facts

Study ID

NCT07660406

Run by

Peking Union Medical College Hospital

People needed

30

Starts

2024-08-01

Expected to finish

2027-10-01

Last updated by the study team

2026-06-22

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a clinical diagnosis of keloids Able to obtain informed consent

You may not qualify if…

• Pregnant women, children, patients with allergies to contrast media Patients with claustrophobia

Where it is running

• Peking Union Medical College Hospital — Beijing, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.